Unlock instant, AI-driven research and patent intelligence for your innovation.

Daptomycin freeze-dried powder injection for injection and production process thereof

A technology of daptomycin and freeze-dried powder injection, applied in the field of medicine, can solve the problems of not examining the quality attributes of injection products, not solving the problem of drug liquid stratification, etc. short time effect

Active Publication Date: 2020-04-24
KINDOS PHARM CO LTD +1
View PDF3 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This patent increases the stability of product content by adding buffer salts and stabilizers, and does not examine other key quality attributes of injection products, nor does it solve the problem of stratification of liquid medicine during the freeze-drying process

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Daptomycin freeze-dried powder injection for injection and production process thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] A daptomycin freeze-dried powder for injection comprises, by mass, 70 parts of daptomycin, 5 parts of isopropanol and dilute to 1000 parts of water for injection.

Embodiment 2

[0029] A daptomycin freeze-dried powder for injection comprises, by mass, 100 parts of daptomycin, 15 parts of methanol and dilute water for injection to 1000 parts.

Embodiment 3

[0031] A daptomycin freeze-dried powder for injection comprises, by mass, 90 parts of daptomycin, 11 parts of tert-butanol and dilute water to 1000 parts.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a daptomycin freeze-dried powder for injection, which comprises the following components in parts by mass: 70-100 parts of daptomycin, 5-15 parts of an organic solvent and thebalance of water for injection, totaling 1000 parts. By adding a small amount of the organic solvent, the product is high in stability, uniform in appearance and short in redissolution time.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a daptomycin freeze-dried powder for injection. Background technique [0002] Daptomycin is a ring lipopeptide antibiotic with a new structure extracted from the fermentation broth of Streptomyces (S. Not only does it have a novel chemical structure, but its mode of action is also different from any approved antibiotic: it disrupts the transport of amino acids by the cell membrane, thereby hindering the biosynthesis of peptidoglycan in the bacterial cell wall, changing the properties of the plasma membrane, It can destroy the function of bacterial cell membrane in many ways, and quickly kill Gram-positive bacteria. In addition to its ability to act on most clinically relevant Gram-positive bacteria, daptomycin is more important for isolates that have shown resistance to methicillin, vancomycin, and linezolid in vitro. Potent activity, this property has very important clinical ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/19A61K38/12A61K47/10A61P31/04
CPCA61K9/0019A61K9/19A61K38/12A61K47/10A61P31/04
Inventor 屈倩倩史宣宇田欣欣
Owner KINDOS PHARM CO LTD